drugset / Trial / NCT07095842

Prehospital Early Administration of Ketamine for Status Epilepticus in Epileptic Kids (PEAK-SEEK)

NCT07095842

Phase 2/3 Recruiting 668 enrolled Sohag University
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this pragmatic, decentralized, pre-consented, event-driven, randomized controlled trial is to investigate the efficacy of add-on ketamine to second-dose midazolam for prehospital treatment of epileptic children with convulsive status epilepticus.

Timeline

Start
2025-08-03
Primary completion
2026-07-30
Completion
2026-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 2 mg/kg Intramuscular
Subject Midazolam Small molecule 0.2 mg/kg Intramuscular

Indications